Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The smarter ones never sold or bought more while we are in the .03s.
JKLM great post. Please tell Waggoner and Crabtree.
Yawn, Holding
Amidst all the panic and turmoil, I am calmly, yawn, holding, excuse me. Calmly holding and waiting for tests results. How are the house hearings with KW going?
They have too many shares. They are making money and diversifying because they are too heavy in this penny stock. It's the smart thing for them to do. I bet they keep a lot as well.
No Doubt JODI.
Jodi, I respectfully disagree. I don't care about traders getting back in easy. The more information, the better for all. Please announce testing results. There is no need for less information.
My last correspondence with IR, a few days ago.
Hi
Oldmusky here. I was wondering if the company could make public any correspondences that you have had with the FDA.
Response from IR:
Dear Oldmusky,
We have several pieces of correspondence with the FDA related to our pre-IND meeting and our request for a second pre-IND meeting. However, all of them are confidential communications with the FDA.
There is nothing to or from the FDA related to our meeting with the FDA in January 2017 or our request for a second meeting in 2019 that we are in a position to share with you or anyone outside of PharmaCyte.
Investor Relations
23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92630
O 917.595.2856 | F 917.595.2851
Yes, I know it was a good post, thanks for letting me know.
Adding more today.
How would PharmaCyte negotiate with big Pharma without the new added shares.
Hi we are PharmaCyte, we have a disruptive technology that will save many lives and has great value but we have no other way to raise money accept your help, please give us a great deal.
OR
Hi we are PharmaCyte , we have a disruptive technology that will save many lives and has great value, we have plenty of shares to bring in money and are looking for the right partner to exploit our technology. Since we are in no great hurry because we can raise more cash we will let you think about it while we shop our therapy around to companies b,c,and d.
I prefer the second option.
How many letters does the SEC get very year with some shareholder of some company crying boo hoo hoo I want my money back. I would be shocked if this letter even made it to someones desk.
Great post!
It seems to me the new intro on this page is designed to hurt existing shareholders.
Here is a post ripe for abuse:
If you were negotiating with big Pharma. First of all, always negotiate from a position of strength real or imagined.
The amount of shares in the float is public knowledge.
Do you as a small biotech in negotiations, appear stronger with shares in the bank to create cash, OR do you appear stronger with no other way to raise money accept big Pharmas help.
sorry if I offended anyone...again
Yup , your the man. Focus your efforts on SEC please, thanks.
Week hands already gone
Thats quite a 180 in attitude about this company, just because they activated shares that were approved by shareholders.
"No Partnership, No buyout" you say
Thermo fisher must of lent us David Judd out of the goodness of there hearts.
Dr Hidalgo (TOP in his field) sang its praises and is running our trial.
We have the support of very accomplished board members who would not be involved if there wasn't potential here.
GMP Validation must be completely wasting their time helping prepare IND.
DR Gunzberg must have spent his life completely wasting his time as well.
A thinly veiled attempt sir.
Nobody is going anywhere. Lol
It really doesn't make sense does it?
Sorry you are leaving. BYE!
Great post A2Z
People sell there shares. Pps. Goes down. Others scoop up cheap shares. Right before IND is filed.
I am holding and I wrote IR.
Email sent!
A submitted IND to the FDA will raise some eyebrows. An IND the has been accepted by the FDA, what is commonly referred to as an open IND will create more market reaction. I would be willing to say an accepted IND will push us up to .35cents. That is a guess off the cuff. I did not volume number crunching. I do like reading others speculation as well.
I agree 1234, the staggered runs make our IND package much more acceptable. Our day is coming soon. IND (Babe the blue OX) is finally being prepared for FDA. Good holiday season for all.
No worries bio, I always respect your posts.
There is no argument. I did not say brokers are recommending it. I said they OWNED it. Brokers from the most renowned brokerage houses are not allowed to recommend penny stocks, only stocks covered by their analysts.
For those wondering, There are plenty of brokers that own this stock. I know a few from the MOST reputable firms. They understand the power of the IND. Once we file our IND more eyes will be upon us. Its going to be a great trade for them, and for me. Good luck to all SERIOUS investors!
That is an incorrect statement. I know two brokers that own it. Keep scratching
I am looking forward to suffering post IND syndrome.
"Unfortunately way too much involved in this and any company to do Due Diligence about."
My friend Redoocs;
I have read every frickin PharmaCyte thing I can find.
I have tried to understand articles in medical journals.
I have thoroughly studied the IND process on the FDA website.
I have even learned just about everything there is to know about the SEC's whistleblower program.
I have learned a lot on dew diligence so my posts are credible.
I also welcome your opinion, just make it a credible one my friend.
I agree with your redundant complaint.
There is never too much dd when money is involved!
With the coming IND approaching for an unmet medical need for LAPC I have no need to roll in the mud and play word circus with you mixer, too many good things happening here!
"Other companies don't read comments from people like me"
Smart companies.
As far as Dr Hidalgo goes there is this:
"After a national search spanning several years, the Weill Department of Medicine (WDOM) is pleased to announce that Dr. Manuel Hidalgo will serve as Chief of the Division of Hematology and Medical Oncology effective June 1, 2019. Recruited from Harvard Medical School, Dr. Hidalgo is currently the Theodore W. and Evelyn G. Berenson Professor of Medicine at Harvard Medical School and serves as Chief of the Division of Hematology/Oncology, as well as the Clinical Director of the Rosenberg Clinical Cancer Center, at Beth Israel Deaconess Medical Center in Boston. He also serves as the Deputy Associate Director for Clinical Sciences at the Dana-Farber/Harvard Cancer Center in Boston.
A premier investigator in the areas of translational and clinical drug development, Dr. Hidalgo has been at the helm of the early clinical development of more than 50 new anticancer agents. Among these agents, he led erlotinib, temsirolimus, and nab-paclitaxel development which are now FDA approved for the treatment of cancer. Nationally and internationally recognized, Dr. Hidalgo is an authority on pancreatic cancer and has published more than 220 articles in the top tier peer-reviewed journals. His immediate goal is to incorporate immune treatment approaches, both in preclinical models and clinical studies, for pancreatic cancer. Dr. Hidalgo’s research funding includes The National Cancer Institute, and he was the recipient of a European Research Council advanced grant. His interests in translational and clinical anticancer drug development began at The University of Texas Health Science Center at San Antonio (UTHSCSA) in San Antonio, Texas, followed by work at Johns Hopkins where he pioneered the development of PDX models (mouse avatar) models for metastatic PDAC."
And board duties here:
https://www.thebalance.com/corporate-board-of-directors-3960038
Very strong board of directors.
On the Cusp of filing the IND(Griffin) for an unmet medical need Cib's Pancreatic Cancer treatment.
If efficacy of treatment is proven then treatment can be expanded to more cancerous tumor types, diabetes, who knows.
Ran extra production run to prove reproducibility. Strengthening IND greatly.
Top Doctor in his field running trial. Dr Manuel Hidalgo.
Constant attention from unnecessarily negative opinions.
Trading at 3.5 pennies.
Perhaps there is an opportunity here I don't know.
Redoocs, we are all aware of the executives salaries. A lot of us are focused on all the recent developments that will break this stock out. You seem to be completely focused on salaries. We got it, they are high, but that will become irrelevant soon. Good luck to you , hope your trades go well here. Can u add anything to the board besides salaries?
Thank you exhibit A.
Yup, you nailed it. Once the IND is filed they will say it will never be accepted.
Once accepted they will say the trial will fail.
Once trial is successful they will say the doctors lied, and on and on and on.
It will only stop when Ciab is used for diabetes and no-one needs to buy insulin anymore. Thats what will end it. Insulin producers making billions, they can afford there own Midam style assault on PharmaCyte, and that is what we are witnessing.
"While we no longer support investing (vs. "TRADING") PMCB,..."
Hello Really, In your statement above who is the "we" you are referring to. Thanks in advance.